Chemical Compound

Rivastigmine tartrate

CAS Registry Number 129101-54-8
Rivastigmine tartrate chemical structure
Primary Record

Rivastigmine tartrate

In stock
7,478 g
Purity
99.7 %
CAS
129101-54-8

Compound Identifiers & Properties

CAS
129101-54-8
PubChem CID
6918078
SMILES
CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
Canonical SMILES
CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O

Names & Synonyms

  • Rivastigmine tartrate
  • Exelon
  • Rivastigmine Hydrogen Tartrate
  • 129101-54-8
  • Rivastigmine bitartrate
  • rivastigmine
  • Prometax
  • Rivastach
  • Rivastigmine actavis
  • Rivastigmine (tartrate)
  • Rivastigmine hydrogentartrate
  • SDZ-ENA 713
  • Exelon MR
  • ENA 713
  • Exelon TDS
  • Nimvastid (TN)
  • Exelon (TN)
  • Rivastigmine L-Tartrate
  • Rivastigmine Tartrate Salt
  • ENA-713
  • Rivastigmine tartrate;
  • AC1OCEZZ
  • RefChem:56915
  • 9IY2357JPE
  • UNII-9IY2357JPE
  • SDZ ENA 713
  • SDZ-ENA-713
  • Rivastigmine tartrate (Exelon)
  • MFCD03700731
  • Rivastigmine tartrate [USP]
  • CHEBI:64358
  • MLS006011143
  • ENA-713D
  • orb1307975
  • Rivastigmine Hydrogen Tartrate;
  • CHEMBL1201092
  • DTXCID4027818
  • DTXSID8047840
  • SCHEMBL29779663
  • GWHQHAUAXRMMOT-MBANBULQSA-N
  • BH001
  • C18H28N2O8
  • HMS3678F17
  • HMS3884H05
  • Rivastigmine for system suitability
  • Rivastigmine hydrogen tartrate CRS
  • ACT03355
  • MSK11245
  • ONO-2540
  • Rivastigmine (tartrate) (Standard)
  • C14H22N2O2.C4H6O6
  • FC0001
  • HY-11017R
  • RIVASTIGMINE TARTRATE [VANDF]
  • s2087
  • AKOS022179413
  • RIVASTIGMINE TARTRATE [USP-RS]
  • (1S)-1-(2,4-dichlorophenyl)ethanol
  • (S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate
  • AC-3487
  • ACN-034451
  • CCG-213410
  • CID6918078
  • CS-0947
  • FR15395
  • Rivastigmine for system suitability CRS
  • RL01405
  • T01R548
  • KS-00000H19
  • SDZ-212-713
  • AS-13921
  • BC225685
  • BR164357
  • DA-67229
  • HY-11017
  • LS-49754
  • Rivastigmine tartrate - Bio-X trade mark
  • SMR004702920
  • RIVASTIGMINE (AS HYDROGEN TARTRATE)
  • RIVASTIGMINE HYDROGEN TARTRATE [MI]
  • RIVASTIGMINE TARTRATE [ORANGE BOOK]
  • AB2000491
  • A8515
  • AM20080949
  • C14-H22-N2-O2.C4-H6-O6
  • FT-0656529
  • R0093
  • RIVASTIGMINE TARTRATE [USP MONOGRAPH]
  • ST24036084
  • SW199663-2
  • RIVASTIGMINE HYDROGEN TARTRATE [MART.]
  • A11719
  • D02558
  • K-4017
  • RIVASTIGMINE HYDROGEN TARTRATE [WHO-DD]
  • RIVASTIGMINE HYDROGEN TARTRATE [EMA EPAR]
  • A805907
  • A966296
  • (2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
  • Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
  • RIVASTIGMINE HYDROGEN TARTRATE [EP MONOGRAPH]
  • Q27133236
  • N0001-009479
  • (2R,3R)-2,3-dihydroxybutanedioic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate
  • [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
  • 3-[(S)-1-(Dimethylamino)ethyl]phenyl N-Ethyl-N-methylcarbamate L-Tartrate
  • Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
  • Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
  • CARBAMIC ACID, N-ETHYL-N-METHYL-, 3-((1S)-1-(DIMETHYLAMINO)ETHYL)PHENYL ESTER, (2R,3R)-2,3-DIHYDROXYBUTANEDIOATE (1:1)
  • N-Ethyl-N-methylcarbamic Acid 3-[(1S)-1-(Dimethylamino)ethyl]phenyl Ester (2R,3R)-2,3-Dihydroxybutanedioate
  • (S)-N-Ethyl-3-[(1-dimethylamino)ethyl]-N-methylphenylcarbamate hydrogen tartrate
  • N-Ethyl-N-methylcarbamic Acid 3-[(S)-1-(Dimethylamino)ethyl]phenyl Ester L-Tartrate
  • Rivastigmine tartrate, 98%, acetylcholinesterase and butyrylcholinesterase inhibitor - 1G 1g
  • (1S)-1-(3-{[ethyl(methyl)carbamoyl]oxy}phenyl)-N,N-dimethylethanaminium (2R,3R)-3-carboxy-2,3-dihydroxypropanoate
  • (2R,3R)-2,3-dihydroxybutanedioic acid; [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
  • (2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methyl-carbamate
  • (S)-Ethylmethylcarbamic Acid 3-[1-(Dimethylamino)ethyl]phenyl Ester [R-(R*,R*)]-2,3-Dihydroxybutanedioate
  • 179237-92-4
  • 3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxybutanedioate
  • 406174-29-6
  • Carbamic Acid, Ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl Ester,(2R,3R)-2,3-dihydroxybutanedioate(1:1)
  • Carbamic acid,ethylmethyl-,3-((1S)-1-(dimethylamino)ethyl)phenyl ester,(2R,3R)-2,3-dihydroxybutanedioate
  • Carbamic acid,N-ethyl-N-methyl-,3-[(1S)-1-(dimethylamino)ethyl]phenyl ester,(2R,3R)-2,3-dihydroxybutanedioate (1:1)
  • Rivastigmine Tartrate; Rivastigmine hydrogen tartrate; 3-[(1S)-1-(Dimethylamino)ethyl]phenyl ethyl(methyl)carbamate hydrogen (2R,3R)-2,3-dihydroxybutanedioate; Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)Carbamic acid, ethylmethyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (9CI); Carbamic acid, ethylmethyl-, 3-[1-(dimethylamino)ethyl]phenyl ester, (S)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1); ENA 713; Rivastigmine hydrogentartrate; Rivastigmine tartrate; SDZ-ENA 713; rivastigmine bitartrate